Open-Label, Sequential Step, Safety and Efficacy Study to Determine the Optimal Single Dose of Ambisome for Patients With VL
Clinical trial NCT00832208 · TERMINATED
Trial details
- NCT number
- NCT00832208
- Sponsor
- Drugs for Neglected Diseases
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2010-09-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.